Begin main content

Reports

We found 4828 result(s)

Selective serotonin reuptake inhibitors (SSRIS) for major depression. Part II: The cost-effectiveness of SSRIs in treatment of depression

Published on: January 1, 1997
Result type: Reports

Recent years have witnessed large increases in expenditures on antidepressants. This has coincided with the introduction and the widespread use of a new class of antidepressants, the selective serotonin reuptake inhibitors (SSRIs). SSRIs are substantially more expensive than the older tricyclic antidepressants (TCAs), but have a different advers...

Tags

Serotonin Uptake Inhibitors, Depressive Disorder, Drug Therapy, Cost-Benefit Analysis, Serotonin Reuptake Inhibitors, Antidepressants, Unipolar Depression, Depression, Depression, SSRIs, Neurotic depression, Economic, Inhibiteur captage sérotonine, Trouble dépressif, Chimiothérapie, Analyse coût bénéfice, ISRS, Inhibiteurs du recaptage de la sérotonine, Antidépresseurs, Dépression névrotique, Évaluation économique

Clinical and economic considerations in the use of fluoroquinolones

Published on: January 1, 1997
Result type: Reports
Product Line: Health Technology Assessment, Technology Overviews

Cite as: Glennie JL. Clinical and economic considerations in the use of fluoroquinolones. Ottawa: Canadian Coordinating Office for Health Technology Assessment (CCOHTA); 1997. Background Fluoroquinolones (also generally referred to as "quinolones") are a class of antimicrobial drugs which, as a group, have a broad spectrum of activity against or...

Tags

Anti-Infective Agents, Ciprofloxacin, Norfloxacin, Ofloxacin, Cystitis, Drug Therapy, Cost-Benefit Analysis, Quinolones, Fluoroquinolones, Infectious Diseases, Infectious diseases, Fluoroquinolone, Bladder infections, Economic, Ciprofloxacine, Cystite, Chimiothérapie, Analyse coût bénéfice, Infections urinaires, Évaluation économique

The Use of G-CSF in the Prevention of Febrile Neutropenia

Published on: January 1, 1997
Result type: Reports
Product Line: Health Technology Assessment, Technology Overviews

Cite as: Perras C, Otten N. The Use of G-CSF in the Prevention of febrile neutropenia. Ottawa: Canadian Coordinating Office for Health Technology Assessment (CCOHTA); 1997. Background Febrile neutropenia is a life-threatening complication of cancer drugs. Granulocyte colony-stimulating factor (G-CSF), reproduced by recombinant DNA technology, st...

Tags

Neutropenia, Granulocyte Colony-Stimulating Factor, Drug Therapy, Antineoplastic Agents, Cost-Benefit Analysis, G-CSF, Chemotherapy, Cancer, Cancer, Cancer drugs, Economic, Neutropénie, Facteur stimulant colonie granulocyte, Chimiothérapie, Antinéoplasiques, Analyse coût bénéfice, Pluripoietine, Anticancéreux, Évaluation économique

Assessment of Techniques for Cervical Cancer Screening

Published on: January 1, 1997
Result type: Reports

Cite as: Noorani HZ. Assessment of techniques for cervical cancer screening. Ottawa: Canadian Coordinating Office for Health Technology Assessment (CCOHTA); 1997. Cervical cancer is one of the few readily preventable forms of cancer. Although the Papanicolaou (Pap) smear has had an enormous impact on the incidence and mortality rates of cervical...

Tags

Cervix Neoplasms, Vaginal Smears, Technology Assessment, Cancer of the Cervix, Infection, Cancer, Cancer, Papovaviridae Infections, Biomedical, Cervical cancer, Pap smears, Papanicolaou smears, Economic, Automated screening, Tumeur col utérus, Frottis vaginal, Papovaviridae, Évaluation technologie biomédicale, Cancer col utérus, Cancer du col, Test Pap, Test de Papanicolaou, Évaluation économique, Contre-dépistage automatiséPapovaviridae Infections,

Pain management clinics in Canada

Published on: January 1, 1997
Result type: Reports
Product Line: Other

Tags

Pain Centers, Pain Management, Pain Clinics, Outpatient Clinics, Ambulatory Care Facilities, Canada, Directory, Outpatient Clinics, Hospital, Anesthesia, Pain relief, Hospital

An Economic Analysis of Sumatriptan for Acute Migraine

Published on: January 1, 1997
Result type: Reports
Product Line: Health Technology Assessment, Technology Overviews

Cite as: Ilersich L. An economic analysis of sumatriptan for acute migraine. Ottawa: Canadian Coordinating Office for Health Technology Assessment (CCOHTA); 1997. Background Migraine is an episodic headache that may be either a steady or throbbing pain. Episodes of migraine can vary in intensity, frequency and duration, and are often accompanied...

Tags

Migraine, Sumatriptan, Vasoconstrictor Agents, Drug Therapy, Costs and Cost Analysis, Meta-Analysis, Vasopressor Agents, Headache Disorders, Headache disorders, Metaanalysis, Economic, Vasoconstricteurs, Chimiothérapie, Coût et analyse coût, Méta-analyse, Agents vasopresseurs, Évaluation économique

Extracorporeal shock wave lithotripsy (ESWL)

Published on: January 1, 1997
Result type: Reports
Product Line: Other

Tags

Lithotripsy, Extracorporeal Shockwave Lithotripsy, Electrohydraulic Shockwave Lithotripsy, Ultrasonic Lithotripsy, Noninvasive Litholapaxy, Equipment and Supplies, Hospital Equipment, Kidney Calculi, Kidney Stones, Ureteral Calculi, Ureterolithiasis, Canada, Directory, Kidney/urologic, ESWL, Hospital

Meta-analysis and Economic Evaluation of Sumatriptan for Migraine

Published on: July 1, 1996
Result type: Reports
Product Line: Health Technology Assessment, Technology Overviews

Cite as: Ilersich L. An economic analysis of sumatriptan for acute migraine. Ottawa: Canadian Coordinating Office for Health Technology Assessment (CCOHTA); 1997. Background Migraine is an episodic headache that may be either a steady or throbbing pain. Episodes of migraine can vary in intensity, frequency and duration, and are often accompanied...

Tags

Migraine, Sumatriptan, Vasoconstrictor Agents, Drug Therapy, Costs and Cost Analysis, Meta-Analysis, Vasopressor Agents, Headache Disorders, Headache disorders, Metaanalysis, Economic, Vasoconstricteurs, Chimiothérapie, Coût et analyse coût, Méta-analyse, Agents vasopresseurs, Évaluation économique, Méta-analyse

Pulmozyme: Clinical and Economic Impacts

Published on: January 1, 1996
Result type: Reports
Product Line: Health Technology Assessment, Technology Overviews

Cite as: Perras C, Otten N. Pulmozyme: clinical and economic impacts. Ottawa: Canadian Coordinating Office for Health Technology Assessment (CCOHTA); 1996. Summary Remarks This overview is based on data obtained in a study commissioned by CCOHTA entitled "A Pharmacoeconomic Evaluation of DNase Use in Cystic Fibrosis" and the Phase III clinical t...

Tags

Cystic Fibrosis, Deoxyribonuclease I, Drug Therapy, Cost-Benefit Analysis, DNase, Streptodornase, Fibrocystic Disease of Pancreas, Cystic Fibrosis, CF, Pulmozyme, Economic